Fri. Dec 4th, 2020

WhyLose.com

Training Traders Since 2002

Bitcoin Weekly Outlook: Expect Choppy Trades Near $16,000

3 min read

The past weeks saw a string of Bitcoin analysts calling for a bull run towards $16,000, a level that it last tested in January 2017 during a corrective downtrend from its record high near $20,000.

The cryptocurrency breached $16,000 on November 11, 2020. Some traders sold-off their positions near the level, causing Bitcoin to correct below it. Nevertheless, any attempt to dump the price below $15,000 met with huge buying demand from traders with a medium- to long-term risk appetite. Hence, Bitcoin reclaimed $16,000 all over again.

Traders have refused to give up the level ever since. It appears like newfound support that could propel the Bitcoin price further higher. In the short-term, supporting the upside outlook is the uncertainty led by a rising number of coronavirus infections in the US.

Coronavirus in Focus

People anticipate the government to reimpose strict social distancing measures that conflict with businesses that rely on close-human interactions. That could hamper the Donald Trump administration’s plans to reopen the US economy fully, thereby hindering a recent recovery in unemployment data and other US economy sectors.

Meanwhile, a worsening pandemic could fuel up the demand for the second coronavirus relief package. The Federal Reserve’s Chairman Jerome Powell warned in the latest officials meeting that their office could not go ahead with ultra-low interest rates and infinite bond-buying without a stimulus.

Bitcoin rose by almost 250% following the first coronavirus stimulus relief in March 2020. Source: BTCUSD on TradingView.com

The relief bill is stuck for months due to a lack of bipartisanship between the Democrat-controlled House of Representatives and the majority-Republican Senate.

An ongoing run-off for two Georgia Senate seats is now the primary focus. Should the Joe Biden-led Democrats win both, their control over Senate would make it easier to pass the second coronavirus package.

If not, then the US economy’s only bullish hope is the vaccine, especially after Pfizer and its pharmaceutical partner BioNTech’s announcement last week. They claimed that their experimental COVID-19 showed 90 percent efficacy.

Both the fundamental drivers offset one another. That allows investors to stay hedged in assets that have the least correlation with the macroeconomic event